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Prognostic models are both a useful everyday tool and an
ongoing ‘‘holy grail’’ in many fields of medicine. Their
potential and use in clinical management of patients can
have significant health, social and economic impact [1–4].
Hence, the search for better, more accurate, and better
discriminating models that require only the most certain
and measurable of input data is an ongoing task [3, 5, 6].
A primary goal is to ensure these models are ade-
quately validated in development. A second major goal in
this search is to ensure utility of the prognostic model
through the need for minimal or straightforward input
data. Finally, it is important to understand the longevity of
such models as they all must change with time, as cohorts,
treatment approaches and clinical cultural changes all
take a toll on their accuracy.
The work presented by Minne et al. [7] in this issue of
Intensive Care Medicine meets all three main goals in
presenting and analysing a SAPS-II-based prognostic
model for mortality in elderly intensive care unit (ICU)
patients. The work is quite unique in its presentation of a
general analysis approach to these models. It presents a
robust prospective validation. More importantly, it anal-
yses the model over a 5-year period with respect to its
predictive performance, including the effect of recali-
bration. As a result, it clearly defines the effective
longevity of the model.
The critical outcome to our minds is the general and
robust framework within which this analysis was
performed. Equally, the approach taken is readily gener-
alisable to any similar problem. Hence, a major part of the
value of this work is in providing a robust, generalisable
and relatively straightforward framework within which to
validate and analyse prognostic models—a significant
achievement that could lead towards standardizing (to an
extent) the approach to such models in the field, as well as
the expectations that the creators of such models would
have to meet. These steps would be a major advance
towards creating more trust and transparency in the
development and use of these models.
As noted by the authors, the use of prognostic models
for mortality has a long history in critical care. One main
use has looked towards managing patient care and treat-
ment decisions [4]. A greater use has been for delineating
and comparing ICU performance or quality [8–10]. Their
use is becoming more evident as critical care resources
become increasingly stressed. However, it is toward this
latter benchmarking use, wherein model predictions must
be adjusted for severity of illness and thus expected
mortality, that this work by Minne et al. [7] raises a
potential intriguing and perhaps slightly mischievous
point.
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Specifically, the results presented are robust in noting
discriminatory power, both with and without repeated
recalibration over time, for multiple parameters. The first
two parameters, area under the receiver operating charac-
teristic curve (AUC) and the Brier score, are both well known
and directly reflect the discriminatory power of the model. It
is no surprise that a proven model with this robust analysis
shows solid, expected results with regard to these metrics.
The third metric—standardized mortality rate (SMR)—
is more interesting. Because SMR is adjusted on the basis
of expected mortality for a cohort it thus reflects the
confluence of observed and predicted mortality. However,
the results in Minne et al. [7], as shown over time, raise an
interesting point. While SAPS-II is relatively constant or
rising over time, SMR without recalibration is falling
steadily in the control chart results presented. Hence, only
15% of ICUs surveyed had SMRs greater than 1, and
repeated recalibration only raised this value to 35%. A
‘‘perfect’’ model would potentially reflect a 50:50 split—
raising questions about SMR as a surrogate of care.
One readily possible cause is simply that all units are
improving the quality of care and that model predictions are
outdated, but this issue would theoretically be managed by
repeated recalibration. However, this behaviour does not
match the results for the more certain and readily measured
AUC or Brier score metrics, which were excellent. Hence,
while there is no ambiguity in the determination of AUC or
Brier score relative to a model, can SMR be affected in
ways that models do not account for?
A potential note of interest is that during the prospec-
tive period of the study, the authors report that the
numbers of beds and admissions had increased from prior
periods in some units studied. In particular, when ICUs
expand they allow greater access to patients who previ-
ously might have been cared for outside of ICU, e.g.
patients undergoing major vascular surgery. Specifically,
prognostic models do not capture effects similar to lead
time bias [11, 12].
In this scenario, under-resourced ICUs might only
accommodate patients that demonstrated failure to
respond to therapy. While non-responders may still have
the same acute physiological derangements as they had
24 h before, they are now clearly different from cohorts
of responders. Thus, if beds are scarce, non-responders
are preferentially admitted and may well have a greater
mortality compared with the broad model prediction, all
else being equal.
Model-evaluated SMR may not adequately reflect this
change without regular reconstruction and/or recalibra-
tion. Equivalently, all models only approximate reality,
and thus a unit might see reduced SMR based simply on
the resulting changes in cohort. This effect is potentially
visible in the results presented comparing before and after
recalibration over 2-month intervals.
The lead time bias conundrum was described in patient
cohorts. When the decision to admit them to an ICU was
made before they responded to treatment [11], mortality
was underestimated. However, in resource-constrained
ICUs patients are frequently selected after they have
failed to respond to treatment. This behaviour might be
better described as treatment-failure bias.
Thus, increasing ICU capacity relative to its demands
and case mix might favourably bias the SMR over time.
More generally, do admissions policies and approaches,
as well as their change over time, bias SMR? Are some
units therefore disadvantaged not as a result of poor care,
but because of external factors less in their control?
These are potentially mischievous questions, but ones that
perhaps should be examined rigorously to ensure that we
meet the first goal of getting prognostic models correctly.
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